Graphical Abstract.
Wess
Günther
G
Aventis Pharma Deutschland GmbH Head of Drug Innovation & Approval (DI&A) Deutschland Building H 825, Industriepark Höchst, 65926 Frankfurt (Germany).
Urmann
Matthias
M
Sickenberger
Birgitt
B